Bradykinin (BK) and its analogs (1 nM-100 muM) stimulated phosphoinosi
tide (PI) turnover in murine fibrosarcoma (HSDM1C1) cells in a concent
ration-dependent manner. The relative potencies (EC50) were: BK = 48 /- 4 nM; Lys-BK = 39 +/- 3 nM; Met-Lys-BK = 158 +/- 33 nM; Des-Arg9-BK
= 2617 +/- 598 nM (means +/- SEM, n = 3-14). All these analogs were f
ull agonists and they produced up to 5.4 +/- 0.4-fold stimulation of P
I turnover at the highest concentration (10-100 muM) of the peptides.
In contrast, the analogs [D-Arg0-HYP3-Thienyl5,8-D-Phe7]-BK (HYP3-anta
gonist), [D-Arg0-HYP3-Thienyl5,8-D-Phe7]-BK (Thienyl antagonist) and D
es-Arg9-Leu8-BK were inactive, as agonists, at 0.1 nM-1 muM in this sy
stem. These data suggested that BK-induced PI turnover in these cells
was mediated via B2-type of BK receptors. This was confirmed further b
y the fact that both the B2-selective Hyp3- and Thienyl-antagonists in
hibited BK-induced PI turnover with K(B)S of 369 +/- 51 nM and 368 +/-
118 nM respectively while the B1-selective antagonist, Des-Arg9-Leu8-
BK, was inactive at 1 muM. [H-3]BK receptor binding studies revealed t
wo binding sites, one with high affinity (K(d) = 0.24 +/- 0.06 nM; B(m
ax) = 1.4 +/- 0.4 pmol/g tissue) and the other with low affinity (K(d)
= 18.5 +/- 0.95 nM; B(max) = 25.1 +/- 0.52 pmol/g tissue), on HSDM1C1
cell homogenates. The rank order of affinity of BK analogs at inhibit
ing specific [H-3]BK binding was similar to that found for PI turnover
. Taken together, these data have provided evidence for the presence o
f two B2-type BK binding sites on the HSDM1C1 cells. Based on the affi
nity parameters, the low-affinity component of [H-3]BK binding in HSDM
1C1 cells appears to be coupled to the phospholipase C-induced PI turn
over mechanism. The high-affinity component has been previously shown
to mediate the production of prostaglandins by activation of phospholi
pase A2.